IMR OpenIR
A new cytotoxic bufadienolide from Chinese medicine Chansu
其他题名A new cytotoxic bufadienolide from Chinese medicine Chansu
Xin Xiu Lan1; Lan Rong1; Huang Jian2; Wang Xiao Jie1; Jia Jing Ming2
2008
发表期刊CHINESE CHEMICAL LETTERS
ISSN1001-8417
卷号19期号:12页码:1445-1446
摘要A new cytotoxic bufadienolide was isolated from the traditional Chinese medicine-Chansu. The structure of new compound was elucidated on the basis of spectral methods including 2D NMR. And it showed strong in vitro cytotoxic activity against Hela cells with IC(50) of 8.06 x 10(-2) mmol/L. (c) 2008 Jing Ming Jia. Published by Elsevier B. V. on behalf of Chinese Chemical Society. All rights reserved.
其他摘要A new cytotoxic bufadienolide was isolated from the traditional Chinese medicine-Chansu. The structure of new compound was elucidated on the basis of spectral methods including 2D NMR. And it showed strong in vitro eytotoxic activity against Hela cells with IC_(50) of 8.06×10(-2)μmol/L.
关键词BUFALIN Bufadienolide Steroid Cytotoxicity Chansu
收录类别CSCD
语种英语
资助项目[PHR (IHLB) the Beijing Ministry of Education]
CSCD记录号CSCD:3585799
引用统计
文献类型期刊论文
条目标识符http://ir.imr.ac.cn/handle/321006/143952
专题中国科学院金属研究所
作者单位1.Beijing Vocat Coll Elect Science & Technol, Beijing 100029, Peoples R China
2.中国科学院金属研究所
推荐引用方式
GB/T 7714
Xin Xiu Lan,Lan Rong,Huang Jian,et al. A new cytotoxic bufadienolide from Chinese medicine Chansu[J]. CHINESE CHEMICAL LETTERS,2008,19(12):1445-1446.
APA Xin Xiu Lan,Lan Rong,Huang Jian,Wang Xiao Jie,&Jia Jing Ming.(2008).A new cytotoxic bufadienolide from Chinese medicine Chansu.CHINESE CHEMICAL LETTERS,19(12),1445-1446.
MLA Xin Xiu Lan,et al."A new cytotoxic bufadienolide from Chinese medicine Chansu".CHINESE CHEMICAL LETTERS 19.12(2008):1445-1446.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xin Xiu Lan]的文章
[Lan Rong]的文章
[Huang Jian]的文章
百度学术
百度学术中相似的文章
[Xin Xiu Lan]的文章
[Lan Rong]的文章
[Huang Jian]的文章
必应学术
必应学术中相似的文章
[Xin Xiu Lan]的文章
[Lan Rong]的文章
[Huang Jian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。